Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemiaKaren L. Bride, David T. Teachey, Stephan A. Grupp et al.|Blood|2018Cited by 226
Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and <i>O</i> 6-methylguanine-DNA methyltransferase activityTerzah M. Horton, Stacey L. Berg|Molecular Cancer Therapeutics|2009Cited by 84
Tumor-associated myeloid cells provide critical support for T-ALLAram Lyu, Lauren I. R. Ehrlich, Todd Triplett et al.|Blood|2020Cited by 27
Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG reportFieke W. Hoff, Terzah M. Horton|Blood|2020Cited by 15
Cells and signals of the leukemic microenvironment that support progression of T-cell acute lymphoblastic leukemia (T-ALL)Aram Lyu, Lauren I. R. Ehrlich, Seo Hee Nam et al.|Experimental & Molecular Medicine|2024Cited by 10